FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Volume 347:382-383 August 8, 2002 Number 6 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited Related Article by Brashear, A. PubMed Citation

Botulinum toxin is in the news these days. First came September 11 and fears of chemical terrorism. One gram of this "most poisonous poison" could kill a million people were it not for problems of delivery. Then, in April 2002, the Food and Drug Administration (FDA) approved the use of botulinum toxin for the treatment of "frown lines" at the glabella, between and above the eyes. This cosmetic use of the toxin has already attracted the interest of countless people who want to look younger. The toxin is also used to erase "crow's feet" — wrinkles at the lateral margin . . . [Full Text of this Article]

This article has been cited by other articles:

• Caty, G. D., Detrembleur, C., Bleyenheuft, C., Deltombe, T., Lejeune, T. M. (2008). Effect of Simultaneous Botulinum Toxin Injections Into Several Muscles on Impairment, Activity, Participation, and Quality of Life Among Stroke Patients Presenting With a Stiff Knee Gait. Stroke 39: 2803-2808 [Abstract] [Full Text]  
• Landau, W. M., Dobkin, B. H., Buitrago, M. M., Koolwijk, I., Brashear, A., Gordon, M. F. (2003). Botulinum Toxin for Spasticity after Stroke. NEJM 348: 258-259 [Full Text]